China Jianyin Investment Ltd, a subsidiary of China sovereign fund China Investment Corporation, and Tamar Alliance Fund will acquire a majority stake in Australia third-largest health supplement company Nature’s Care. The financial terms are not disclosed but according to industry source, the valuation of the company is believed to be around AU$800 million. The deal still subjected to Australian authorities’ approval. The consortium was advised by Deutsche Bank, while Nature’s Care was advised by UBS on the deal.
The Nature’s Care story began in 1990 when the company founder and Managing Director, Jina Wu began researching natural remedies to help cure her father’s persistent seasonal cough. The company has since grown to annual revenues of more than AU$200 million and employs about 200 staffs.
Today, Nature’s Care products which include vitamins & nutritional supplement, baby formulas and skincare products, are distributed all over the world from the company’s Australian manufacturing plant, 30km north of Sydney. Nature’s Care products can be found in the USA, Canada, China, Taiwan, Japan, Korea, Hong Kong, Thailand and throughout Australian supermarket chains Coles and Woolworths, as well as pharmacies Priceline and Chemist Warehouse.